TRIM58 and neoplasm: The ability of TRIM58 to suppress tumor formation in vivo was investigated using tumor xenograft experiments in which subcutaneous tumor growth was compared among severe combined immunodeficient (SCID) mice transplanted with different stable A549 transfectants.